![George Lloyd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Lloyd
Direttore degli Investimenti presso
RP Management LLC
Patrimonio netto: 631 M $ in data 31/08/2026
Profilo
Attualmente, George Lloyd ricopre la posizione di Executive VP-Investments & General Counsel presso RP Management LLC e Executive VP-Investments & General Counsel presso Royalty Pharma Plc. È anche nel consiglio di amministrazione di Royalty Pharma Holdings Ltd. In passato è stato socio presso Goodwin Procter LLP, associato presso Davis Polk & Wardwell LLP e socio presso Testa, Hurwitz & Thibeault LLP. Si è laureato alla Princeton University e si è laureato alla New York Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 3,53% | 08/08/2025 | 7.527.320 ( 3,53% ) | 462 M $ | 31/08/2026 |
ROYALTY PHARMA PLC 7,93% | 16/05/2025 | 1.944.471 ( 7,93% ) | 119 M $ | 31/08/2026 |
| 18/12/2025 | 779.915 ( 0,18% ) | 48 M $ | 31/08/2026 | |
RPI International Holdings 2019 LP
 RPI International Holdings 2019 LP Financial ConglomeratesFinance Functions as an investment fund 0,07% | 18/06/2020 | 20.500 ( 0,07% ) | 1 M $ | 31/08/2026 |
Posizioni attive di George Lloyd
| Società | Posizione | Inizio |
|---|---|---|
RP Management LLC
 RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Direttore degli Investimenti | 18/05/2011 |
Royalty Pharma Holdings Ltd.
 Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | 10/06/2020 |
Precedenti posizioni note di George Lloyd
| Società | Posizione | Fine |
|---|---|---|
| ROYALTY PHARMA PLC | Direttore degli Investimenti | 31/12/2025 |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Testa, Hurwitz & Thibeault LLP
 Testa, Hurwitz & Thibeault LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Formazione di George Lloyd
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
43
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Testa, Hurwitz & Thibeault LLP
Testa, Hurwitz & Thibeault LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RP Management LLC
RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Finance |
New York Law School
 New York Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
